Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
2
50%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

unknown250%
terminated125%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_3

Surgical Idiopathic Intracranial Hypertension Treatment Trial

NCT03501966
unknownphase_2

The Role of Optic Nerve Sheath Fenestration in Leukemic Patients Having Increased Intracranial Pressure

NCT04431882
completednot_applicable

Optic Nerve Sheath Fenestration

NCT00337961
unknownnot_applicable

Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition

NCT00306657

Clinical Trials (4)

Showing 4 of 4 trials
NCT03501966Phase 3

Surgical Idiopathic Intracranial Hypertension Treatment Trial

Terminated
NCT04431882Phase 2

The Role of Optic Nerve Sheath Fenestration in Leukemic Patients Having Increased Intracranial Pressure

Unknown
NCT00337961Not Applicable

Optic Nerve Sheath Fenestration

Completed
NCT00306657Not Applicable

Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4